Table 2.
Drugs | Major CYP | f u‐blood a | f u‐mic a | Predicted CLh (mL/min) | In vivo (mL/min) a , c | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dispersion model | Well‐stirred model | Parallel tube model | |||||||||
Canonical | New | Canonical | New | Canonical | New | ||||||
Coumarin | 2A6 | 0.02 | 0.99 b | 971 ~ 1,357 | 547 ~ 718 | 814 ~ 1,151 | 508 ~ 622 | 1,048 ~ 1,418 | 606 ~ 765 | 625 | |
Paclitaxel | 2C8 | 0.12 | 0.66 | 215 ~ 484 | 187 ~ 364 | 204 ~ 436 | 179 ~ 335 | 219 ~ 507 | 190 ~ 376 | 141 | |
Propafenone | 2D6 | 0.06 | 0.26 | 1,329 ~ 1,444 | 822 ~ 919 | 1,119 ~ 1,320 | 701 ~ 775 | 1,400 ~ 1,449 | 881 ~ 990 | 400 | |
Midazolam | 3A4 | 0.07 | 0.54 | 1,260 ~ 1,436 | 1,060 ~ 1,256 | 1,050 ~ 1,288 | 884 ~ 1,046 | 1,345 ~ 1,449 | 1,146 ~ 1,341 | 429 | |
Indinavir | 0.40 | 0.97 | 1,190 ~ 1,425 | 1,028 ~ 1,264 | 988 ~ 1,256 | 859 ~ 1,054 | 1,279 ~ 1,447 | 1,111 ~ 1,349 | 624 | ||
Cyclosporine | 0.07 | 0.37 | 281 ~ 669 | 236 ~ 462 | 263 ~ 584 | 223 ~ 418 | 288 ~ 711 | 241 ~ 482 | 209 | ||
Saquinavir | 0.02 | 0.58 | 1,292 ~ 1,440 | 876 ~ 1,005 | 1,081 ~ 1,303 | 742 ~ 841 | 1,372 ~ 1,449 | 942 ~ 1,085 | 452 | ||
Cabazitaxel | 0.1 | 0.42 b | 1,051 ~ 1,389 | 855 ~ 1,120 | 876 ~ 1,193 | 726 ~ 931 | 1,135 ~ 1,435 | 919 ~ 1,209 | 790 | ||
Docetaxel | 0.07 | 0.01 b | 1,286 ~ 1,440 | 1,024 ~ 1,194 | 1,075 ~ 1,300 | 855 ~ 991 | 1,367 ~ 1,449 | 1,106 ~ 1,283 | 504 | ||
Valspodar | 0.02 | 0.07 b | 721 ~ 1,215 | 467 ~ 650 | 624 ~ 1,010 | 422 ~ 568 | 769 ~ 1,304 | 488 ~ 689 | 182 | ||
Felodipine | 0.01 | 0.08 | 1,179 ~ 1,423 | 1,042 ~ 1,289 | 979 ~ 1,251 | 869 ~ 1,077 | 1,269 ~ 1,446 | 1,125 ~ 1,369 | 829 |
CLh, hepatic clearance; f u‐blood, drugs unbound fraction in blood; f u‐mic, drugs unbound fraction in microsome.
See Supplementary Excel File for references of f u‐blood, f u‐mic and in vivo .
f u‐mic of coumarin, cabazitaxel, docetaxel, and valspodar were estimated using this equation, as they have not been measured. 17 Microsomal protein concentrations (C) for coumarin, cabazitaxel, docetaxel, and valspodar were 0.03, 0.5, 1, and 1 mg/mL, respectively. Log P = 1.39 for coumarin and Log D 7.4 = 3.3 for cabazitaxel were calculated using ACD/Labs Percepta Platform—PhysChem Module. Log D 7.4 = 6.5 and 4.5 for docetaxel and valspodar were referenced by Bu, 2006.
See Methods and Supplementary Excel File for detailed derivation of in vivo CLh.